NCT07146490: Ex-Irisin

Effects of Different Types of Exercise on Irisin and Cognitive Performance (Exercise-Irisin)

Completed NA Last updated 4 September 2025

What this trial tests

NA trial testing Low Exercise in Irisin in 12 participants. Completed in 5 August 2025.

Timeline

10 June 2025

Primary endpoint
27 July 2025

5 August 2025

Quick facts

Lead sponsor	Aksaray University Training and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	12
Start date	10 June 2025
Primary completion	27 July 2025
Estimated completion	5 August 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Low Exercise
• Long Interval Exercise
• Short Intevral Exercise

Conditions studied

• Irisin — all drugs for Irisin →
• Lactate — all drugs for Lactate →
• Cognitive Function — all drugs for Cognitive Function →
• Exercise Training — all drugs for Exercise Training →

Sponsor

Aksaray University Training and Research Hospital

Who can join

Adults 18 to 25, male only, with Irisin or Lactate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose The purpose of this study was to determine the acute effects of different exercise intensities on Irisin levels, trail making test performance, and feeling scale.

Method

This randomized crossover controlled trial aims to examine the acute effects of three experimental conditions-Short-Interval High-Intensity Interval Training (SI-HIIT), Long-Interval High-Intensity Interval Training (LI-HIIT) and Low-Intensity Continuous Training (LICT), on cognitive performance (via the Trial Making Test, ) and associated neurochemical responses (e.g., serum Irisin and blood lactate levels) in healthy young adults aged 18-25 years.

All participants completed the three conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of three groups (n = 4 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-3) and that the order minimized sequence effects by rotating the position of each condition relative to the others.

To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (Irisin increases reported -no two high-intensity sessions were scheduled consecutively. Where possible, higher and lower intensity protocols were be alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.

The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis.

All exercise sessions conducted under supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol in the morning (09:00-11:00) on a track and field pitch to control for chronobiological variation. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were to remain unchanged throughout the study.

During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed, aerobic capacity, and peak heart rate.

In the following four visits, each participant completed all experimental conditions. Each exercise session began with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.

All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's maximal aerobic speed, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's maximal aerobic speed, ensuring workload equivalence across conditions.

* Short-interval high-Intensity Interval Training: Participants ran at 110-120% of their MAS for 15-second intervals.
* Long-interval high-Intensity Interval Training: Participants ran at a speed corresponding to 80-90% of their MAS.
* Low-Intensity Continuous Training: Participants ran continuously for 24 minutes at 50-60% of their MAS without breaks.

Venous blood samples were collected before and immediately after each session to assess neurochemical markers. Subsequently, cognitive performance was evaluated using the computerized Trial Making Test to measure executive function. Heart rate was continuously monitored during all exercise conditions using a Polar V800 device. Following each session, psychophysiological responses were assessed using the Feeling Scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.